Holly Yin, PH.D.
PRECISION MEDICINE EXPERT
Dr. Yin has 15 years of experience in drug discovery and development, both in academic and industry (Novartis) settings. With her expertise in both academic and industrial background, she had the opportunity to develop a wide network of collaborators, both with 14 academic and 13 industrial partners, domestically and internationally. During the past decade at TGen, she has successfully lead/completed 48 NIH funded and pharmaceutical company sponsored screening projects with the fully-optimized state-of-the-art high-throughput screening pipeline. These have had total combined costs of more than $30,000,000. She held and filed 12 patents, published 27 peer-reviewed scientific publications, and presented 58 meeting abstracts at various national and international conferences. Among these projects, several have already succeeded in moving novel combination therapies into clinical trials.